Shares Of SELLAS Life Sciences Group Inc (NASDAQ: SLS) Could Show A Loss Of -86.05%

In the last trading session, 3.1 million shares of the SELLAS Life Sciences Group Inc (NASDAQ:SLS) were traded, and its beta was 2.28. Most recently the company’s share price was $1.72, and it changed around $0.01 or 0.58% from the last close, which brings the market valuation of the company to $162.63M. SLS currently trades at a discount to its 52-week high of $1.85, offering almost -7.56% off that amount. The share price’s 52-week low was $0.77, which indicates that the current value has risen by an impressive 55.23% since then.

SELLAS Life Sciences Group Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SLS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.

SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information

Instantly SLS has showed a green trend with a performance of 0.58% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.8500 on recent trading dayincreased the stock’s daily price by 7.03%. The company’s shares are currently up 65.38% year-to-date, but still up 20.28% over the last five days. On the other hand, SELLAS Life Sciences Group Inc (NASDAQ:SLS) is 65.38% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $2.8, which translates to bulls needing to increase their stock price by 38.57% from its current value. Analyst projections state that SLS is forecast to be at a low of $2.4 and a high of $3.2.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 45.94%. SELLAS Life Sciences Group Inc earnings are expected to increase by 15.00% in 2025, but the outlook is positive 42.51% per year for the next five years.

SLS Dividends

SELLAS Life Sciences Group Inc’s next quarterly earnings report is expected to be released in June.

SUSQUEHANNA INTERNATIONAL GROUP, LLP, with 3.6594% or 1.64 million shares worth $1.95 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.69 shares worth $2.91 million, making up 1.79% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 501.97 shares worth around $0.86 million, which represents about 0.53% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.